RICTOR amplification has been described in 10% of NSCLCs, and mutations in the tumor suppressor genes PTEN and STK11, which are negative regulators of mTOR signaling, have also been observed in squamous cell and adenocarcinomas [101–103]. Here, RICTOR is linked to adenocarcinoma.